NCT05117918

Overactive Bladder Telemedicine Non-inferiority Trial

A Prospective Study Evaluating the Feasibility of Telemedicine Use in the Overactive Bladder Clinical Care Pathway: a Non-inferiority Study Assessing Patient Satisfaction and Progression to Third Line Overactive Bladder Therapies

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 177 (actual)
• Sponsor: University of California, Los Angeles · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

In this study, the investigators aim to validate the telemedicine paradigm as a feasible alternative to traditional in-person clinic visits for the management of overactive bladder (OAB).

Detailed description

This is a single-center, prospective randomized controlled trial. The study population will consist of two primary cohorts stratified based on the method of follow-up, either traditional in-person clinic visit or telemedicine appointment. The primary outcome will be satisfaction with OAB treatment. Secondary endpoints include rate of progression to third line therapies, changes in OAB symptom scores, safety, and cost. This non-inferiority trial is designed to provide an alternative option for care delivery that may result in improved patient satisfaction and compliance, and decreased cost, time, and travel burden for patients.

Conditions

• Overactive Bladder

Interventions

Type	Name	Description
OTHER	SUFU Clinical Care Pathway for Overactive Bladder	Treatment of OAB via the SUFU clinical care pathway
OTHER	Telemedicine	Delivery of care via telemedicine

Timeline

• Start date: 2021-07-01
• Primary completion: 2023-08-31
• Completion: 2023-08-31
• First posted: 2021-11-11
• Last updated: 2023-12-12

Locations

1 site across 1 country: United States